Kenvue Beats Q1 Sales Estimates, Reports $0.32 Adjusted EPS
KVUE sits 26% above its 52-week low of $14.02.
Summary
Kenvue reported strong first-quarter results, with sales reaching $3,909 million, surpassing the IBES estimate of $3,842 million. The company also announced adjusted earnings per share of $0.32 and GAAP EPS of $0.25. This positive performance indicates solid operational execution and market demand for its consumer health products, providing a favorable update following its recent annual report which detailed restructuring plans and product liability lawsuits. Traders will be watching for further details on segment performance and any updates on the ongoing legal and restructuring efforts.
At the time of this announcement, KVUE was trading at $17.60 on NYSE in the Trade & Services sector, with a market capitalization of approximately $33.9B. The 52-week trading range was $14.02 to $25.17. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.